Chrome Extension
WeChat Mini Program
Use on ChatGLM

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

International Journal of Drug Policy(2023)

Cited 6|Views17
No score
Abstract
•COVID-19 pandemic led to amendments to regulations for opioid medications.•Most providers supported flexibilities around take-homes, despite initial caution.•Providers developed new processes to make decisions around take-homes.•Flexibility around take-homes favoured person-centred care approaches.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined